Bronspiegel–Zelnick Syndrome

Bronspiegel–Zelnick syndrome is another name for aplasia cutis congenita–intestinal lymphangiectasia syndrome. Babies are born with aplasia cutis congenita (ACC)—a patch where scalp skin is missing, usually on the top of the head—and they also have intestinal lymphangiectasia (IL), a problem in the gut’s lymph vessels that leaks protein and lymph cells. This leak causes general body swelling (edema), low blood proteins (hypoproteinemia), and low lymphocyte counts (lymphopenia). Only two cases (two brothers) have ever been published, and there have been no new medical reports since 1985. Genetic Diseases Center+2Wikipedia+2

“Bronspiegel-Zelnick syndrome” describes a very rare combination seen at birth: a patch where the scalp skin never formed (aplasia cutis congenita, usually on the top of the head) together with leaky intestinal lymph vessels (primary intestinal lymphangiectasia). The gut lymph leakage makes blood proteins and immune cells spill into the intestine, so babies develop swelling (edema), very low albumin, and low lymphocyte counts. The term comes from the first report in two brothers; since then, medicine has used more precise names—ACC and PIL—to guide diagnosis and treatment. In practical care, clinicians manage the skin defect like ACC and manage the gut leak and low proteins like PIL/PLE. Genetic Diseases Center+2Orpha+2

Why it happens

In PIL, the tiny lymph vessels that carry fat and immune cells from the intestine are dilated or malformed. When pressure rises inside them, they ooze lymph into the bowel. Lymph is rich in albumin, antibodies, and lymphocytes; losing it causes edema, poor weight gain, vitamin deficiencies, and greater infection risk. A strict diet that reduces long-chain fat and uses medium-chain triglycerides (MCT) can “bypass” the intestinal lymphatics, lowering pressure and leak. In ACC, a small area of skin on the scalp fails to develop in utero; care aims to keep it clean, prevent infection, and, for larger or deep defects, close it surgically or with grafts. NCBI+3PMC+3PGHN+3

In the 1985 report, one brother did better on a special diet (very low long-chain fat with medium-chain triglycerides, or MCTs) and higher protein; the other died at two months from sudden bleeding from a vein in the skull area under the scalp defect. This shows how serious the skull/skin gap can be and how important careful protection and nutrition are. PubMed

Inheritance. Catalogs list this syndrome under autosomal-recessive inheritance (you need two altered copies of the gene, one from each parent), but the exact gene is unknown because only two children have been described. Genetic Diseases Center

Bottom line in one line: It is a newborn condition combining a scalp skin defect and a protein-losing gut lymph vessel disorder, producing swelling, low protein, and low lymphocytes—documented only twice, long ago. Genetic Diseases Center+1

Other names

• Aplasia cutis congenita–intestinal lymphangiectasia syndrome

• Bronspiegel–Zelnick syndrome

• Autosomal recessive aplasia cutis (term used in listings for this entity) Genetic Diseases Center+1

Types

There are no official subtypes because there are only two known cases. For communication, clinicians might still describe two practical, descriptive patterns (not formal categories):

1. ACC-dominant presentation. The scalp defect is the biggest early concern (risk of bleeding or infection overlying venous sinuses). Supportive neurosurgical and wound care take priority. (This reflects the fatal course in one brother.) PubMed

2. IL-dominant presentation. The protein-losing enteropathy stands out (generalized edema, low albumin/total protein, lymphopenia) and stabilizes with nutrition (high protein, low long-chain fat, MCTs). (This reflects the improvement in the surviving brother.) PubMed+2PMC+2

These “types” are just descriptive ways to talk about which problem is clinically dominant at a given time; they are not separate diseases.

Causes

Because the exact gene is unknown and only two cases exist, proven causes can’t be listed. Instead, here are 20 plausible, evidence-informed contributors grouped by what we know about ACC, intestinal lymphangiectasia, and lymphatic development in general. I’ll clearly label when this is direct evidence for this syndrome (rare) vs inference from related conditions.

1. Autosomal-recessive inheritance (direct listing). Rare-disease catalogs group this entity as autosomal recessive, consistent with two affected brothers and unaffected parents. This points to a hidden gene change passed by both parents. Genetic Diseases Center

2. Embryonic scalp skin development error (inferred from ACC). ACC often results from a local failure of skin (and sometimes bone) to form on the scalp midline before birth. The exact trigger varies; here it likely co-exists with lymphatic defects. NCBI

3. Developmental defect of intestinal lymphatics (inferred from IL). In IL, lacteals (tiny gut lymph vessels) are dilated and leaky, causing protein loss into the intestines; that explains edema and low proteins. PubMed

4. Shared ectoderm–mesoderm disruption (directly suggested by the 1985 paper). The original authors proposed a combined anomaly affecting both skin (ectoderm-derived) and lymphatic/mesodermal structures. PubMed

5. Candidate lymphatic-development genes (inference). Genes like CCBE1, FLT4/VEGFR3, ADAMTS3, PIEZO1, EPHB4, FOXC2 can cause primary lymphatic disorders/lymphedema; variants in a similar pathway could underlie IL here, although this has not been proven for this syndrome. PMC+2ScienceDirect+2

6. Candidate ACC-related genes (inference). Research links ACC in some families to genes that affect cranial skin development (e.g., KCTD1/KCTD15 or genes in other ACC-associated syndromes). This suggests possible pathways but no gene is confirmed for Bronspiegel–Zelnick syndrome. Medscape+1

7. Primary lymphedema spectrum (inference). The same developmental biology that produces congenital lymphedema can involve gut lymphatics, yielding IL with protein loss. BMJ Global Health

8. Fetal lymphatic flow/pressure abnormalities (inference). When central lymphatic flow is abnormal (e.g., in central conducting lymphatic anomalies), babies may develop generalized swelling and chylous effusions; gut lymphatics could be part of that continuum. JCI

9. Protein-losing enteropathy (mechanistic link). IL triggers protein loss into the gut; low albumin lowers oncotic pressure and causes edema—this is a cause-and-effect driver of symptoms. UVA School of Medicine

10. Nutrient malabsorption (mechanistic link). Dilated lacteals reduce fat absorption, causing poor growth, diarrhea, and vitamin deficiencies; this worsens illness unless diet is adjusted (low long-chain fat, MCT). PMC+1

11. Lymphopenia (mechanistic link). Loss of lymph into the gut lowers circulating lymphocytes, increasing infection risk. This is central to the phenotype. Genetic Diseases Center

12. Coagulation disturbances (inference). Protein loss can reduce clotting factors; combined with skull/venous sinus exposure under the ACC lesion, bleeding risk increases (as seen in one brother). PubMed

13. Perinatal trauma overlay (inference). A large scalp defect at birth can be fragile; minor trauma may precipitate bleeding or infection, worsening outcomes even if the root cause is genetic.

14. Infection risk (mechanistic). Open scalp area plus lymphopenia can increase infection risk, which can worsen swelling and healing.

15. Micronutrient deficiencies (inference). Fat-soluble vitamins (A, D, E, K) can fall with fat malabsorption in IL, affecting immunity, bone health, and clotting. UVA School of Medicine

16. Secondary edema drivers (inference). Very low albumin alone can cause anasarca; this amplifies swelling independent of lymphatic obstruction. UVA School of Medicine

17. Unknown environmental or stochastic developmental factors (acknowledged uncertainty). ACC sometimes shows no identifiable trigger; random developmental errors may contribute. NCBI

18. Placental/vascular events (inference from ACC literature). Some ACC reports link lesions to placental infarcts or vascular disruptions during fetal life; this is hypothetical here. Spandidos Publications

19. Syndromic overlap genes (inference). Rare ACC-plus syndromes (e.g., Adams–Oliver) illustrate that “skin + vascular/lymphatic” patterns can share pathways; this is a conceptual cause, not a proven one here. PMC

20. Founder effect in a population (inference). The two brothers were reported as Ashkenazi Jewish; an unrecognized founder variant is possible, but unproven. Wikipedia

Symptoms and signs

Only a tiny number of patients exist, so most features below come from the two reported brothers or from how ACC and IL behave generally. I’ll note when a feature is drawn from those sources.

1. Scalp skin missing at birth (ACC). A round/oval area on the top of the head lacks skin; sometimes the bone under it is thin or missing. This area needs gentle protection to prevent bleeding or infection. PubMed

2. Generalized swelling (edema). Puffy face, limbs, and sometimes belly (ascites) from protein loss and lymphatic leakage. Genetic Diseases Center

3. Low blood protein (hypoproteinemia). Blood tests show low albumin and total protein due to protein-losing enteropathy; this drives edema and fatigue. Genetic Diseases Center

4. Low lymphocyte count (lymphopenia). Lymph cells are lost into the intestines; blood tests show reduced lymphocytes, increasing infection risks. Genetic Diseases Center

5. Poor weight gain/failure to thrive. Energy and nutrients are lost; growth can be slow without nutrition therapy. (Typical of IL.) BioMed Central

6. Diarrhea or bulky, greasy stools. Fat malabsorption from dilated lacteals leads to steatorrhea unless diet is modified. PMC

7. Easy bruising or bleeding risk. Low proteins (including clotting factors) and exposed venous sinuses under ACC can increase bleeding risk, as reported in one infant. PubMed

8. Infections more often. Lymphopenia can weaken immune defenses; skin barrier loss also raises risk. Genetic Diseases Center

9. Irritability/feeding problems. Discomfort from swelling and gut symptoms can make feeding hard in newborns.

10. Large soft spot or skull defect under the scalp lesion. Imaging may show a bony gap beneath ACC; careful handling is essential. PubMed

11. Ascites or pleural effusions (some cases). Protein and lymph leak can cause fluid in the abdomen or chest in lymphatic disorders; not documented in those two brothers but common in severe IL. (Inference.) PMC

12. Dry, fragile wound surface over ACC. The lesion crusts and can ulcerate; infection risk rises until healed. (General ACC feature.) NCBI

13. Fat-soluble vitamin deficiency signs. Easy bruising (vitamin K), bone issues (vitamin D), vision issues in deficiency states (vitamin A), or neuropathy (vitamin E)—potential in chronic IL without supplementation. (Inference.) UVA School of Medicine

14. Pitting vs non-pitting limb swelling. Early edema from low albumin pits; chronic lymphatic swelling can become non-pitting. (General physiology.) UVA School of Medicine

15. Tiredness/low energy. Low protein, micronutrient losses, and frequent illness can make infants listless unless nutrition is corrected. (General IL/PLE effect.) UVA School of Medicine

Diagnostic tests

Important: There is no single “Bronspiegel–Zelnick test.” Doctors diagnose it by recognizing the unique combination of ACC of the scalp and objective evidence of intestinal lymphangiectasia with protein-losing enteropathy—and by ruling out other causes of edema and low proteins. PubMed

A) Physical examination (at the bedside)

1. Detailed scalp exam. Identify the size, depth, and location of the ACC patch; look for crusting, exposed tissue, bleeding risk, or signs of infection. (ACC evaluation.) NCBI

2. Edema assessment. Check for generalized swelling, whether it pits to touch, and if there’s ascites or scrotal/labial swelling—clues to protein-loss and lymphatic issues. UVA School of Medicine

3. Growth and nutrition check. Weight, length, head circumference plotted over time to detect failure to thrive from malabsorption. BioMed Central

4. Skin/wound infection signs. Redness, warmth, discharge at the ACC site—important due to open barrier.

5. Respiratory status and chest exam. Listen and percuss for pleural fluid if breathing is labored (lymphatic disorders can cause effusions). (Inference.) PMC

B) Manual tests and simple bedside maneuvers

6. Pitting test for edema. Gentle pressure leaves a dent in hypoalbuminemic edema; chronic lymphatic swelling becomes less pitting—helps separate mechanisms. UVA School of Medicine

7. Stemmer sign. Try to pinch the skin at the base of a toe or finger; if it’s hard to lift a fold, it suggests lymphedema component. (General lymphatic sign.) BMJ Global Health

8. Head protection and gentle pressure test. Very careful palpation over ACC to detect underlying bony gap or tenderness; reinforces the need for protective dressings. (ACC care.) NCBI

9. Abdominal girth tracking. Serial tape measurements to follow ascites (if present) day-to-day; a simple, useful trend.

10. Nutritional intake diaries. In IL, tracking fat/protein intake and stool features helps connect diet to symptoms and lab changes. PMC

C) Laboratory and pathological tests

11. Serum albumin and total protein. Low levels confirm the protein-losing state that explains generalized edema. Genetic Diseases Center

12. Complete blood count with differential. Lymphopenia is expected in IL; anemia can develop with chronic disease or bleeding. Genetic Diseases Center

13. Stool α-1 antitrypsin clearance. Elevated values point to protein-losing enteropathy from intestinal leakage. (Standard PLE test.) UVA School of Medicine

14. Fat-soluble vitamin levels (A, D, E, K) and micronutrients. Detect malabsorption and guide supplementation in IL. UVA School of Medicine

15. Coagulation profile (PT/INR, aPTT). Low vitamin K or loss of clotting proteins can prolong times; essential before any procedure near the scalp lesion. (PLE/IL care.) UVA School of Medicine

16. Serum immunoglobulins. Protein and lymph loss can reduce Ig levels; helps explain infection risk and guide replacement if needed. (PLE physiology.) UVA School of Medicine

17. Urinalysis and urine protein. Rules out kidney protein loss as an alternative cause of low albumin (nephrotic syndrome).

18. Small-intestinal biopsy (pathology). Endoscopic biopsy showing dilated lacteals confirms intestinal lymphangiectasia. (This was used in the index case.) PubMed

D) Electro-diagnostic or electrical tests (used to rule out other causes)

19. Electrocardiogram (ECG). Not specific for this syndrome, but helps exclude cardiac causes of edema or assess strain if there are large effusions. (Pragmatic differential check.)

Note: Classic nerve conduction studies/EMG are not relevant here; “electrodiagnostic” in this context is limited to ECG or impedance-based assessments to sort out edema causes.

E) Imaging tests

20. Skull imaging under the ACC patch. Cranial ultrasound (through the soft spot), CT, or MRI can show bony defects beneath ACC and the relationship to venous sinuses—vital for safety planning. (Imaging was part of care in the 1985 report’s context.) PubMed

Non-pharmacological treatments (evidence-grounded essentials)

1. Strict low-fat, high-protein diet with MCT oil – Cornerstone therapy to reduce lymph flow/pressure and replace lost protein; improves edema and albumin. MCTs absorb directly into portal blood and bypass intestinal lymphatics. PMC+1

2. Essential fatty acids & fat-soluble vitamin (A, D, E, K) repletion (dietary planning) – Prevents deficiency when long-chain fats are restricted. PGHN

3. Salt and fluid management for edema – Dietary sodium limits plus careful fluid strategy complement albumin infusions if used. UVA School of Medicine

4. Growth-focused nutrition program – Frequent calorie/protein adjustments with a dietitian to sustain catch-up growth and immune recovery. PMC

5. ACC wound care (small lesions) – Gentle cleansing, moisture-balancing dressings, infection watch; many small scalp ACC lesions epithelialize without surgery. NCBI

6. Early surgical consult for large/deep ACC – For exposed bone/dura or large defects, plan timely closure (local flaps/skin grafts) to protect the brain and reduce infection risk. PMC+1

7. Physiotherapy & developmental follow-up – Malnutrition/edema can delay milestones; early intervention supports motor skills and growth. PMC

8. Infection prevention (immunization on time; nutrition-linked immune support) – PLE lowers IgG/lymphocytes; keeping vaccines up-to-date and nutritional status optimized reduces infection risk. UVA School of Medicine

9. Dermatology & neurosurgery co-management for ACC – Multidisciplinary planning improves timing and method of scalp reconstruction. Surgical Neurology International

10. Lymphatic imaging-guided planning – In selected cases, characterizing focal vs diffuse lymph leaks may open interventional options (embolization/bypass). PGHN

11. Albumin-sparing lifestyle tips – Prompt diarrhea care, avoidance of high-fat “cheat days,” and close follow-up during intercurrent illness to prevent decompensation. UVA School of Medicine

12. Family counseling & long-term monitoring – Education on diet adherence, signs of relapse, and growth/vitamin checks improves outcomes. PMC

In comprehensive reviews and national guidance, dietary therapy is repeatedly identified as first-line and most effective for PIL; the remaining measures support, personalize, or enable that core approach. PMC+1

Drug treatments you may see used

Because there are no trials in “Bronspiegel-Zelnick syndrome,” medicines are chosen from the PIL/PLE toolbox, targeted to symptoms, imaging pattern (focal vs diffuse), and response to diet:

• Albumin infusions (IV) – Short-term correction of severe hypoalbuminemia with diuretic pairing to mobilize edema; bridge while diet takes effect. BioMed Central

• Loop diuretics – Symptomatic edema control after/with albumin; careful dosing to avoid electrolyte loss. BioMed Central

• Octreotide (somatostatin analogue) – Can reduce intestinal lymph flow in some PLE/PIL cases; responses are variable and less reliable in extensive disease. PMC+1

• Sirolimus (mTOR inhibitor) – Growing evidence for complex/diffuse lymphatic malformations and refractory PIL; case series suggest good responses when diet alone is insufficient. Requires monitoring (lipids, blood counts). BioMed Central+1

• Everolimus (mTOR class) – Alternative to sirolimus in select refractory cases under specialist care. WJGnet

• Tranexamic acid – Occasionally used adjunct in PIL/PLE; evidence is limited and individualized. WJGnet

• Loperamide / stool-bulking agents – Symptomatic diarrhea control and comfort. Medscape

• Proton-pump inhibitor or H2 blocker – Protects upper GI mucosa during periods of severe edema/hypoproteinemia and when using certain meds. Medscape

• Fat-soluble vitamin supplements (A, D, E, K) & essential fatty acids – Pharmacologic dosing to correct deficiency caused by fat restriction and losses. PGHN

• Calcium/vitamin D & bone protection – For children with longstanding malabsorption or on mTOR therapy. PGHN

• Parenteral nutrition (short term, selected cases) – If oral/enteral steps fail during acute decompensation to restore nutrition and buy time. UVA School of Medicine

• Antibiotics (targeted, not routine) – Only if infected ACC lesion or intercurrent infection; not a baseline therapy. NCBI

• Topical antimicrobials for ACC (short course as needed) – If colonization/infection risk around the scalp defect rises. NCBI

Newer series and reviews emphasize diet first, albumin/diuretics as needed, and mTOR inhibition (sirolimus) for diffuse/refractory lymphangiectasia; octreotide works in some but not all patients. Decisions are individualized and specialist-led. PMC+1

Dietary molecular supplements

• MCT oil – Core supplement that provides calories and fat while bypassing lymphatic transport; doses are tailored by dietitians to growth and tolerance. PMC

• Essential fatty acid add-backs (e.g., linoleic/alpha-linolenic acid) – Prevents deficiency when long-chain fats are restricted. PGHN

• Fat-soluble vitamins (A, D, E, K) – Pharmacologic replacement to avoid vision, bone, nerve, and clotting problems from losses/restriction. PGHN

• High-protein modulars (whey/casein isolates) – Concentrated protein to replete serum albumin and support growth. UVA School of Medicine

• Electrolyte/trace mineral solutions – Replace losses and support diuretic use when needed. UVA School of Medicine

These are prescribed and titrated by the clinical team; there is no role for unverified “lymph detox” supplements. The safest and most effective “supplement” in PIL remains MCT within a dietitian-designed plan. PMC

Immunity-booster / regenerative / stem-cell drugs

There are no approved immune-booster or stem-cell drugs for PIL/ACC. Management improves immunity indirectly by stopping protein/IgG loss and correcting malnutrition. IVIG is sometimes considered if severe hypogammaglobulinemia persists with infections despite nutritional control, but that is individualized. mTOR inhibitors (sirolimus/everolimus) are lymphatic-targeted, not “immune boosters.” UVA School of Medicine+1

Procedures and surgeries (when and why)

• ACC closure (flaps/skin grafts) – For large scalp defects or exposed bone/dura to prevent infection and protect the brain; timing is individualized to size and depth. PMC+1

• Localized intestinal lymphangiectasia resection – If imaging shows a focal leaking segment, surgical removal can be curative or reduce leak. BioMed Central

• Interventional lymphatic procedures (embolization/bypass) – In selected centers, lymphatic embolization or lymphovenous bypass may target identified leak points in refractory cases. PGHN

Prevention & day-to-day precautions

• Stick to the MCT-based diet; relapse often follows high-fat intake. PMC

• Routine vaccines & infection hygiene (handwashing, prompt care for fevers). UVA School of Medicine

• Regular labs (albumin, lymphocytes, vitamins, minerals) and growth checks. BioMed Central

• Early management of diarrhea/vomiting to prevent precipitous protein drops. UVA School of Medicine

• Protect the ACC site (until fully healed) from trauma/sun; follow wound-care plans. NCBI

When to see a doctor urgently

Call or seek care if there is increasing swelling, breathing difficulty, fever, oozing or redness from the scalp lesion, poor feeding, lethargy, new diarrhea, or any signs of dehydration. For known PIL/PLE, new edema or rapid weight gain can signal a protein drop and may need albumin/diuretic rescue while diet is re-optimized. UVA School of Medicine

What to eat & what to avoid

• Eat: high-protein foods; fruits/vegetables; grains; MCT oil as the primary fat; physician-guided essential fatty acid add-backs; vitamin ADEK supplements as prescribed. PMC+1

• Avoid/limit: long-chain-fat-heavy foods (butter, cream, fatty meats, deep-fried foods); unsupervised “keto” or high-fat diets; abrupt diet breaks (“cheat meals”) that can trigger edema relapse. PMC

---

Frequently asked questions

1) Is Bronspiegel-Zelnick a different disease from PIL and ACC?
No. It’s an older synonym for the reported association of ACC + PIL in two brothers. Modern care uses the ACC and PIL frameworks for diagnosis/treatment. Genetic Diseases Center+1

2) What is the single most important treatment?
A strict low-fat, high-protein diet with MCT oil; it directly reduces lymph leakage and improves albumin and edema. PMC

3) Do medicines cure the lymph leak?
Medicines help symptoms or difficult cases (e.g., sirolimus for diffuse lymphatic anomalies; octreotide sometimes helps), but diet remains first-line. BioMed Central+1

4) Will my child always need albumin infusions?
Often only during flares or initial stabilization; the goal is to reduce or stop infusions as diet control improves losses. BioMed Central

5) Can surgery fix the gut leak?
Only if imaging shows a focal leaking segment; diffuse disease is rarely surgical but may be considered for interventional lymphatic procedures in specialized centers. BioMed Central+1

6) How are scalp (ACC) lesions handled?
Small lesions are often managed conservatively; large/deep lesions need planned closure to protect underlying structures. NCBI+1

7) What vitamin supplements are necessary?
Fat-soluble vitamins (A, D, E, K) and essential fatty acids are commonly replaced under medical supervision in PIL. PGHN

8) Is sirolimus safe for children?
It’s used by specialists for refractory lymphatic disease with monitoring. Reports show benefit, but it’s not first-line and requires lab follow-up. BioMed Central+1

9) Can octreotide be tried?
Yes, but response is inconsistent; it may be less effective in extensive disease. PMC+1

10) What checks should we do regularly?
Weight, growth, edema score, albumin/total protein, lymphocytes, vitamins ADEK, electrolytes/minerals, and diet adherence. BioMed Central

11) Is the condition genetic?
PIL can be part of broader lymphatic abnormalities; genetics vary across lymphatic disorders. The original “Bronspiegel-Zelnick” report did not establish a discrete gene. JAMA Network

12) Does PLE increase infection risk?
Yes—loss of antibodies and lymphocytes increases risk; vaccination and nutrition help mitigate it. UVA School of Medicine

13) Could we ever relax the diet?
Only cautiously and under supervision; many patients relapse with liberal fats. PMC

14) Are there national care recommendations?
Recent national guidance and reviews for PIL emphasize diet first, selective meds (e.g., sirolimus), and multidisciplinary follow-up. BioMed Central+1

15) Why is information so scarce?
Because the eponym refers to two brothers described in 1985; since then, clinicians talk in terms of ACC and PIL/PLE, where the evidence resides. Genetic Diseases Center+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 20, 2025.